NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open2,220
High2,233.4
Low2,205.2
Prev. Close2,226.1
Avg. Traded Price2,222.68
Volume4,82,745
MARKET DEPTH
Total bid51,656.00
Total ask64,922.00
| Orders | Qty | Bid |
|---|
| 1 | 1 | 2224.8 |
| 3 | 49 | 2224.7 |
| 1 | 9 | 2224.4 |
| 4 | 53 | 2224.3 |
| 6 | 110 | 2224.2 |
| Ask | Qty | Orders |
|---|
| 2224.9 | 1 | 1 |
| 2225 | 2 | 105 |
| 2225.1 | 3 | 38 |
| 2225.2 | 1 | 20 |
| 2225.3 | 3 | 9 |
HIGH/LOW
LOW/HIGH
₹2,205.202 hours ago
₹2,233.402 hours ago
Bandhan Small Cap Fund-Reg(G)
Invesco India Midcap Fund(G)
3Y Return+31.8%
NAV₹183.12
Motilal Oswal Nifty Midcap 100 ETF
Invesco India Large & Mid Cap Fund(G)
3Y Return+28.9%
NAV₹102.18
Glenmark Pharmaceuticals Limited is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark’s ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark’s formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.
